In what some people might consider a surprising turn of events, global pharmaceutical company GlaxoSmithKline (GSK) will be collaborating with biotech company Adaptimmune, which specialises in experimental cancer treatments.
The reason that this might come as a surprise is because it was......
Read the full story at: GSK and Adaptimmune Cancer Research Collaboration
Monday 16 June 2014
Daily Diamond - GSK and Adaptimmune Cancer Research Collaboration
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment